medmix AG
MEDX.SW
Get informed when a big investor buys or sells
+ FollowMarket Cap$397.37M
Close$
$8.01
19.3% downside
Current Fair Value
19.3% downsideOvervalued by 19.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $397.37 Million |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $0.10 (1.02%) |
| Earnings per Share | $0.16 |
| Beta | 0.83 |
| Outstanding Shares | 40,706,198 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 3908 |
|---|---|
| PEG | -4218.16 |
| Price to Sales | 0.45 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 24, 2026
EPS Estimate
$0.35
Average shareholder expectationRevenue Estimate
$231.00 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About medmix AG
2,587 employees
CEO: Rene Willi Established in 1922 and headquartered in Zug, Switzerland, Medmix AG stands as a global leader in innovating, manufacturing, and distributing high-precision devices and services. These solutions are meticulously engineered for the contro...